Singapore markets open in 3 hours 43 minutes

Nuvation Bio Inc. (NUVB)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
3.4700-0.0500 (-1.42%)
At close: 04:00PM EDT
3.6500 +0.18 (+5.19%)
After hours: 04:01PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 900.87M
Enterprise value 165.96M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.25
Enterprise value/revenue N/A
Enterprise value/EBITDA -1.63

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-74.29%
S&P500 52-week change 3-5.29%
52-week high 314.7200
52-week low 33.4600
50-day moving average 34.9566
200-day moving average 37.2754

Share statistics

Avg vol (3-month) 3897.88k
Avg vol (10-day) 3664.64k
Shares outstanding 5217.13M
Implied shares outstanding 6N/A
Float 8124.06M
% held by insiders 127.07%
% held by institutions 172.35%
Shares short (12 May 2022) 417.03M
Short ratio (12 May 2022) 421.16
Short % of float (12 May 2022) 420.09%
Short % of shares outstanding (12 May 2022) 47.81%
Shares short (prior month 13 Apr 2022) 416.92M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-7.67%
Return on equity (ttm)-11.47%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -97.04M
Net income avi to common (ttm)-87.74M
Diluted EPS (ttm)-0.4200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)737.7M
Total cash per share (mrq)3.38
Total debt (mrq)6.74M
Total debt/equity (mrq)0.93
Current ratio (mrq)34.89
Book value per share (mrq)3.32

Cash flow statement

Operating cash flow (ttm)-78.39M
Levered free cash flow (ttm)-46.84M